ARWR
Arrowhead Pharmaceuticals Inc
61.50$
-0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13,869.6% | +105.8% | +4.0% | -6.7% | -59.7% | -81.5% | +11.9% | +1,447.3% | +207.9% | +38.9% | -11.3% | +1.4% | -32.0% | -20.1% | +16.4% | -72.1% | +179.1% | +54.0% | +39.9% | -16.6% | -28.3% | +453.2% | -78.6% | -2.6% | +98.1% | +133.9% | -89.2% | +1.7% | -77.9% | -100.0% | – | – | -89.4% | +21,608.4% | -94.9% | +823.7% | +2.9% | -72.1% | +2.1% | – | |
| – | -27.1% | -23.0% | -0.3% | +28.2% | -9.1% | -10.2% | +6.5% | +37.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | +0.5% | +0.7% | +2.2% | +1.1% | -0.7% | +22.7% | +17.8% | +10.5% | +6.1% | +5.7% | +5.1% | +4.2% | +16.2% | +2.3% | +2.6% | +0.1% | -0.3% | – | – | |
| – | +13,869.6% | +105.8% | +4.0% | -6.7% | -59.7% | -81.5% | +11.9% | +1,447.3% | +207.9% | +38.9% | -11.3% | +1.4% | -32.0% | -20.1% | +16.3% | -72.1% | +179.1% | +54.0% | +39.9% | -16.6% | -35.0% | +500.1% | -80.0% | -3.0% | +107.0% | +139.9% | -91.3% | -2.5% | -105.8% | – | – | – | – | +21,608.4% | -94.9% | +823.7% | +2.9% | -72.1% | +2.1% | – | |
| – | -18.4% | -26.8% | -1.0% | +19.9% | +1.8% | +28.8% | +0.2% | +35.7% | +11.0% | +19.7% | -6.8% | +21.9% | -0.2% | +26.8% | +10.5% | +34.2% | -12.7% | +22.3% | +32.7% | +10.9% | -3.3% | +16.1% | -5.2% | +15.9% | +0.4% | -10.8% | +26.5% | +4.9% | +16.8% | -13.9% | +52.7% | -11.3% | +4.3% | -2.8% | +22.0% | +7.6% | +1.4% | -2.2% | +14.4% | – | |
| – | -34.8% | -57.0% | +6.6% | +143.1% | -53.9% | -16.4% | +25.1% | +40.0% | -4.6% | -13.0% | -9.9% | +113.5% | +5.0% | +49.9% | -34.5% | +34.7% | -39.4% | +87.2% | +10.3% | +114.4% | -35.8% | +37.7% | -3.3% | -3.4% | -34.9% | +10.9% | +2.4% | +3.4% | -4.0% | +6.3% | -5.9% | +11.2% | +2.4% | +5.7% | +9.1% | +22.1% | +22.4% | -9.4% | +13.1% | – | |
| – | -27.1% | -23.0% | -0.2% | +28.2% | -9.1% | -10.2% | +6.5% | +37.0% | +6.3% | +10.8% | -7.5% | +41.0% | +1.5% | +34.3% | -5.9% | +34.0% | -19.0% | +34.6% | +27.4% | +32.7% | -14.5% | +22.1% | -4.6% | +9.8% | -9.5% | -6.4% | +20.8% | +4.6% | +12.7% | -10.4% | +40.8% | -8.3% | +4.3% | -1.5% | +19.7% | +9.9% | +5.1% | -3.7% | +14.1% | – | |
| – | – | – | – | – | – | – | – | – | – | +101.1% | -15.5% | -48.2% | -150.4% | – | – | – | – | – | – | – | – | – | -275.5% | – | – | – | -313.2% | – | – | – | – | – | – | – | -143.4% | – | -7.5% | -446.1% | – | – | |
| – | -90.5% | -99.6% | +120,695.6% | +216.0% | -60.6% | -99.9% | +186,243.6% | +234.2% | +4.1% | -99.8% | +92,142.4% | +299.9% | -68.7% | -99.9% | +96,987.5% | +293.7% | -100.0% | -29.7% | -16.0% | +378.1% | -81.1% | -8.8% | +17.6% | +27.7% | +80.0% | +77.5% | +2.0% | +2.0% | +2.0% | +35.0% | -29.7% | +187.5% | +47.8% | 0.0% | +12.7% | -11.0% | +3.7% | +6.0% | +3.0% | – | |
| – | – | – | – | – | – | – | – | – | – | +98.5% | -14.9% | -41.6% | -122.5% | – | – | – | – | – | – | – | – | – | -262.4% | – | – | – | -316.8% | – | – | – | – | – | – | – | -148.5% | – | -21.7% | -586.6% | – | – | |
| – | -62,974.1% | – | – | – | -25,702.9% | – | – | – | -112.1% | – | – | – | -99.7% | – | – | – | -90,475.0% | – | – | – | -57,900.0% | – | – | – | -99.6% | -5,976.5% | – | +172.9% | -263.6% | – | – | – | -81.1% | +1,601.9% | -124.9% | – | -99.9% | -75.9% | +57.1% | – | |
| – | – | – | – | – | – | – | – | – | – | +98.5% | -14.9% | -42.4% | -122.8% | – | – | – | – | – | – | – | – | – | -262.4% | – | – | – | -311.5% | – | – | – | – | – | – | – | -147.3% | – | – | -530.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | +91.3% | -15.5% | -45.3% | -133.5% | – | – | – | – | – | – | – | – | – | -247.9% | – | – | – | -271.4% | – | – | – | – | – | – | – | -137.4% | – | -11.0% | -287.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.